SAGE
Ensign Peak Advisors’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-44,021
| Closed | -$239K | – | 1720 |
|
|
2024
Q4 | $239K | Buy |
44,021
+1,300
| +3% | +$7.06K | ﹤0.01% | 1690 |
|
|
2024
Q3 | $308K | Buy |
42,721
+13,200
| +45% | +$95.3K | ﹤0.01% | 1672 |
|
|
2024
Q2 | $321K | Hold |
29,521
| – | – | ﹤0.01% | 1675 |
|
|
2024
Q1 | $553K | Sell |
29,521
-1,489
| -5% | -$27.9K | ﹤0.01% | 1598 |
|
|
2023
Q4 | $672K | Hold |
31,010
| – | – | ﹤0.01% | 1583 |
|
|
2023
Q3 | $638K | Hold |
31,010
| – | – | ﹤0.01% | 1501 |
|
|
2023
Q2 | $1.46M | Hold |
31,010
| – | – | ﹤0.01% | 1003 |
|
|
2023
Q1 | $1.3M | Hold |
31,010
| – | – | ﹤0.01% | 1033 |
|
|
2022
Q4 | $1.18M | Buy |
31,010
+15,950
| +106% | +$608K | ﹤0.01% | 1036 |
|
|
2022
Q3 | $590K | Buy |
15,060
+7,120
| +90% | +$279K | ﹤0.01% | 1368 |
|
|
2022
Q2 | $256K | Hold |
7,940
| – | – | ﹤0.01% | 1721 |
|
|
2022
Q1 | $263K | Hold |
7,940
| – | – | ﹤0.01% | 1795 |
|
|
2021
Q4 | $338K | Sell |
7,940
-13,627
| -63% | -$580K | ﹤0.01% | 1772 |
|
|
2021
Q3 | $956K | Sell |
21,567
-7,745
| -26% | -$343K | ﹤0.01% | 1451 |
|
|
2021
Q2 | $1.67M | Buy |
29,312
+8,752
| +43% | +$497K | ﹤0.01% | 1225 |
|
|
2021
Q1 | $1.54M | Sell |
20,560
-5,490
| -21% | -$411K | ﹤0.01% | 1234 |
|
|
2020
Q4 | $2.25M | Hold |
26,050
| – | – | 0.01% | 988 |
|
|
2020
Q3 | $1.59M | Buy |
26,050
+13,066
| +101% | +$799K | ﹤0.01% | 1097 |
|
|
2020
Q2 | $539K | Sell |
12,984
-2,115
| -14% | -$87.8K | ﹤0.01% | 1447 |
|
|
2020
Q1 | $433K | Sell |
15,099
-4,257
| -22% | -$122K | ﹤0.01% | 1425 |
|
|
2019
Q4 | $1.4M | Buy |
+19,356
| New | +$1.4M | ﹤0.01% | 1207 |
|